Even if you can’t see that smile right now, we know you’ll be able to see our commitment to safety throughout our facilities. We’re following CDC guidelines for hygiene, infection control and social distancing to ensure you get the care you need, in the safest environment possible.
Call 911 if you think you are experiencing a life-threatening emergency.
We have resumed elective procedures, services and appointments following guidelines from the Centers for Disease Control and Prevention (CDC) and public health authorities, using the best practices for hygiene, infection control and social distancing. Our hospital, emergency department and outpatient and immediate care centers are fully prepared and ready to safely welcome you back to get the care you need. Don’t wait to be well.
The health and safety of our patients and those who serve them is our highest priority. NCH and our caregivers are responding to this unprecedented pandemic with unwavering dedication. We need your support.
NCH is in the process of vaccinating patients aged 65+. Appointment availability may vary based on vaccine inventory. NCH will continue to use NCH MyChart to notify eligible patients when we have the vaccine available. Please ensure your Communication Preferences are up to date under Account Settings in your MyChart account.
To ensure you are prepared for vaccination distribution view the appropriate information below.
NCH is communicating directly with our current patients 65 and older through email with steps to prepare to receive the vaccine as we get doses from the appropriate local public health agencies.
At this time NCH is only preparing to vaccinate individuals 65 and older along with health care workers in the existing 1a group. Frontline essential workers (in Phase 1b) can receive vaccine access information by contacting their local public health agencies:
The State of Illinois is now in COVID-19 Vaccine Phase 1b for residents age 65 and older, and frontline essential workers. Residents under the age of 65 will be part of the next cohort group in Phase 1c.